. A Single-Center, Open-Label, Phase II, Proof-of-Concept Study with Pasireotide LAR in patients with progressive medullary thyroid cancer (MTC) and the combination with RAD001 upon progression (Abstract/Poster in atti di convegno)

Type
Label
  • . A Single-Center, Open-Label, Phase II, Proof-of-Concept Study with Pasireotide LAR in patients with progressive medullary thyroid cancer (MTC) and the combination with RAD001 upon progression (Abstract/Poster in atti di convegno) (literal)
Anno
  • 2014-01-01T00:00:00+01:00 (literal)
Alternative label
  • A. Faggiano, V. Ramundo, F. Marciello, M. Del Prete, R. Severino, S. De Luca, V. Marotta, A. Carratù, L. Pezzullo, P. Ferolla, G. Vitale, M.G. Chiofalo, L. Camera, R. Fonti, A. Colao (2014)
    . A Single-Center, Open-Label, Phase II, Proof-of-Concept Study with Pasireotide LAR in patients with progressive medullary thyroid cancer (MTC) and the combination with RAD001 upon progression
    in Congress of the European Neuroendocrine Association, Sofia, Bulgaria, 10-13 September 2014.
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • A. Faggiano, V. Ramundo, F. Marciello, M. Del Prete, R. Severino, S. De Luca, V. Marotta, A. Carratù, L. Pezzullo, P. Ferolla, G. Vitale, M.G. Chiofalo, L. Camera, R. Fonti, A. Colao (literal)
Note
  • Abstract (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Università Federico II di Napoli, IBB-CNR (literal)
Titolo
  • . A Single-Center, Open-Label, Phase II, Proof-of-Concept Study with Pasireotide LAR in patients with progressive medullary thyroid cancer (MTC) and the combination with RAD001 upon progression (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
data.CNR.it